Lior Raviv | Vice President Of Development
Pluristem

Lior Raviv, Vice President Of Development, Pluristem

Rachel has worked in clinical research for over 8 years and is currently a Senior Project Manager for The CLINICAL TRIAL CompanyTM (TCTC).  Rachel’s research career started in 2011 with GlaxoSmithKline as a Clinical Research Scientist (Study Manager) before moving to Scope International UK and then TCTC in 2015. Rachel achieved Silver award at the International Clinical Researcher of the Year Awards in 2016.

Rachel has worked across all clinical phases (I-IV) with a focus on complex advanced therapy trials, working closely with innovative biopharma across different therapeutic areas. Rachel is currently the project director of a portfolio of paediatric gene therapy studies in rare diseases across the US and Europe.

Rachel has a BSc (Hons) Biochemistry from the University of Warwick, is a Registered Member of the Institute of Clinical Research, and has been published in the European Journal of Drug Metabolism and Pharmacokinetics and Lambert Academic publishing.

Appearances:



Conference Day 1: Thursday 16th May 2019 @ 12:10

Technology and Strategy Roundtables

25 senior level tables hosted by thought leaders on key challenges and opportunities in next-generation therapeutic development. Participants are invited to join the group discussions on a topic of importance to them.· At each roundtable, the moderator will talk for 5 minutes to introduce the topic highlighting particular challenges specific to that area· The table will then move on to discussion for 25 minutes.· There will then be one rotation, giving participants the opportunity to have join two round tables in total(2 x 30-minute rotations and max 15 PAX)

Table 21. Automation and continuous manufacture

Conference Day 1: Thursday 16th May 2019 @ 17:45

BIOPROCESSING CLOSING PLENARY: Bioprocessing Panel discussion: How to manage cell and gene therapy delivery from ‘end to end’ 

  • Sample collection, handling and logistics 
  • Regulation 
  • Product distribution 
  • Cryo-shipping strategies 
  • Manufacturing automation and cell therapy 
  • Reimbursement and integrated care 

Conference Day 1: Thursday 16th May 2019 @ 17:45

Panel discussion: How to manage cell and gene therapy delivery from ‘end to end’

  • Sample collection, handling and logistics 
  • Regulation 
  • Product distribution 
  • Cryo-shipping strategies 
  • Manufacturing automation and cell therapy 
  • Reimbursement and integrated care 
last published: 21/Mar/19 09:25 GMT

back to speakers

There are two parts to the World Advanced Therapies & Regenerative Medicine Congress: a conference and an exhibition featuring solutions for pharma and biotech.

There is a registration fee to attend the conferences. To visit the exhibition is free.

TO SPONSOR / EXHIBIT

Erica Baeta 
+44 (0)207 092 1152 
erica.baeta@terrapinn.com

TO SPEAK

Jessica Robinson 
t/ +44 (0)207 092 1150 
jessica.robinson@terrapinn.com

TO REGISTER

Issa Mauthoor 
+44 (0)207 092 1257 
issa.mauthoor@terrapinn.com